Using RT-PCR, CYP1A1 was measured in mammary carcinoma cells that were treated prior with 1 μM of DMBA in both the absence and presence of curcumin and after 24 h, a 15-fold increase in CYP1A1 mRNA was observed [170]. The gene discussed is CYP1A1; the disease is breast carcinoma.